Fig. 7

Effect of the individual and combined treatments with prostratin and NSC87877 on BM-MNCs. a) Relative colony numbers of BM-MNCs collected from AML patients upon treatment with drugs versus vehicle-treated cells. b) The same representation as in panel a) showing clonogenicity of healthy donor (HD)-derived BM-MNCs upon drug treatments. Values for each sample are individually plotted in different colors as indicated in the legend and box-plots are displayed as data summary. Asterisks (*) indicate statistical significance versus untreated cells and hashes (#) against NSC-treated cells